Roads to advanced vaccines: influenza case study

Vaccines represent a cornerstone to ensure healthy lives and promote well‐being for all at all ages. However, there are many diseases for which vaccines are not available, are relatively ineffective or need to be adapted periodically. Advances in microbial biotechnology will contribute to overcoming...

Descripción completa

Detalles Bibliográficos
Autores principales: Riese, Peggy, Guzmán, Carlos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Goal 3. Ensure healthy lives and promote well‐being for all at all ages
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609253/
https://www.ncbi.nlm.nih.gov/pubmed/28809451
http://dx.doi.org/10.1111/1751-7915.12835
_version_ 1783265577252421632
author Riese, Peggy
Guzmán, Carlos A.
author_facet Riese, Peggy
Guzmán, Carlos A.
author_sort Riese, Peggy
collection PubMed
description Vaccines represent a cornerstone to ensure healthy lives and promote well‐being for all at all ages. However, there are many diseases for which vaccines are not available, are relatively ineffective or need to be adapted periodically. Advances in microbial biotechnology will contribute to overcoming these roadblocks by laying the groundwork for improving and creating new approaches for developing better vaccines, as illustrated here in the case of influenza.
format Online
Article
Text
id pubmed-5609253
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56092532017-09-25 Roads to advanced vaccines: influenza case study Riese, Peggy Guzmán, Carlos A. Microb Biotechnol Goal 3. Ensure healthy lives and promote well‐being for all at all ages Vaccines represent a cornerstone to ensure healthy lives and promote well‐being for all at all ages. However, there are many diseases for which vaccines are not available, are relatively ineffective or need to be adapted periodically. Advances in microbial biotechnology will contribute to overcoming these roadblocks by laying the groundwork for improving and creating new approaches for developing better vaccines, as illustrated here in the case of influenza. John Wiley and Sons Inc. 2017-08-15 /pmc/articles/PMC5609253/ /pubmed/28809451 http://dx.doi.org/10.1111/1751-7915.12835 Text en © 2017 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Goal 3. Ensure healthy lives and promote well‐being for all at all ages
Riese, Peggy
Guzmán, Carlos A.
Roads to advanced vaccines: influenza case study
title Roads to advanced vaccines: influenza case study
title_full Roads to advanced vaccines: influenza case study
title_fullStr Roads to advanced vaccines: influenza case study
title_full_unstemmed Roads to advanced vaccines: influenza case study
title_short Roads to advanced vaccines: influenza case study
title_sort roads to advanced vaccines: influenza case study
topic Goal 3. Ensure healthy lives and promote well‐being for all at all ages
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609253/
https://www.ncbi.nlm.nih.gov/pubmed/28809451
http://dx.doi.org/10.1111/1751-7915.12835
work_keys_str_mv AT riesepeggy roadstoadvancedvaccinesinfluenzacasestudy
AT guzmancarlosa roadstoadvancedvaccinesinfluenzacasestudy

Ejemplares similares